Rare diseases
Investigational molecules
Locations
Back to France1 clinical trial in Monceau-les-mines, France. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on ER-positive/HER2-negative metastatic breast cancer are exploring new combination therapy approaches. These studies aim to evaluate the effectiveness of combining targeted therapies with hormone treatments.
Research emphasizes monitoring treatment response through circulating tumor DNA analysis, enabling more personalized treatment approaches for breast cancer patients.
Studies are investigating the role of biomarker detection in guiding treatment decisions for advanced breast cancer. This research focuses on identifying specific mutations that may influence treatment effectiveness.
The research aims to optimize treatment strategies by monitoring specific molecular changes during therapy.
Clinical investigations are evaluating the safety profile of combination therapies in metastatic breast cancer treatment. Special attention is given to monitoring and managing potential hematological effects.
These studies aim to establish optimal treatment protocols while maintaining patient safety and quality of life.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
